Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6RZ7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,673
Award facts
- Contract value 100% obligated
- $29,672.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,672.70 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 6, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector medication, with final delivery required by January 7, 2026. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The contract encompasses a comprehensive global pharmaceutical support vehicle enabling the delivery of brand-name and generic drugs, vaccines, specialty medications, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to efficiently fulfill government requirements across multiple therapeutic domains. This delivery order for Repatha, a specialty cardiovascular medication, exemplifies the company's role in supplying essential prescription pharmaceuticals to support military treatment facilities and federal medical institutions through established contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F6RZ7?
SPE2DR26F6RZ7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F6RZ7 worth?
The government has obligated $29,673 on SPE2DR26F6RZ7.
Is contract SPE2DR26F6RZ7 an order under another contract?
Yes. SPE2DR26F6RZ7 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6RZ7 competed?
The extent of competition for SPE2DR26F6RZ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award